Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004091729 | SCV003559047 | uncertain significance | not specified | 2021-08-02 | criteria provided, single submitter | clinical testing | The c.1712C>T (p.S571L) alteration is located in exon 15 (coding exon 14) of the FNDC3A gene. This alteration results from a C to T substitution at nucleotide position 1712, causing the serine (S) at amino acid position 571 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004695396 | SCV005192146 | uncertain significance | not provided | criteria provided, single submitter | not provided |